RiboNova
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
100 E Lancaster Ave, Wynnewood, Pennsylv...Phone Number
(610) 801-2541Website
www.ribonova.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About RiboNova
RiboNova is dedicated to discovering and developing novel medicines for patients suffering from serious rare diseases, particularly mitochondrial diseases. Their lead product candidate, R007, is a Phase-2 ready small molecule aimed at treating inherited mitochondrial disease, which affects approximately 75,000 people in the United States. The company focuses on addressing the significant burden of mitochondrial diseases through innovative drug discovery. RiboNova's intended clients are patients with rare diseases and their families seeking effective treatment options.Explore more
RiboNova Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RiboNova your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if RiboNova had a recent Job posting/layoffs
Check if RiboNova has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once RiboNova has new funding data
Congratulate Masked Content for being promoted to Masked Content at RiboNova
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when RiboNova launches new products
Earning: See what the market has to say on RiboNova recently announced quarterly report
Check out if RiboNova is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
RiboNova, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined RiboNova as Masked Content
Find more new buyers
Compare Similar Companies to RiboNova
Compare insights from companies similar to RiboNova, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RiboNova is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
RiboNova is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about RiboNova.
RiboNova financials insights
Gather financial insights about RiboNova, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$31K
RiboNova Tech Stack
A closer look at the technologies used by RiboNova
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RiboNova
Sign Up For FreeTo access detailed company insights
RiboNova is dedicated to discovering and developing novel medicines for patients suffering from serious rare diseases, particularly mitochondrial diseases. Their lead product candidate, R007, is a Phase-2 ready small molecule aimed at treating inherited mitochondrial disease, which affects approximately 75,000 people in the United States. The compa... Read More
